8-K: NexGel Secures $2 Million in Registered Direct Offering to Bolster Growth

NexGel, Inc. has announced a registered direct offering expected to raise $2 million to support working capital, inventory, and potential acquisitions.

Summary

• NexGel, Inc. has entered into subscription agreements for a registered direct offering of 363,636 units at $5.50 per unit.
• Each unit includes two shares of common stock and a warrant to purchase one share of common stock at an exercise price of $4.25.
• The offering is expected to close around November 13, 2024, and will result in the issuance of 727,272 shares of common stock and warrants for 363,636 shares.
• The warrants are exercisable immediately and expire five years from the closing date, with a cashless exercise option if a registration statement is not available.
• The gross proceeds from the offering are estimated to be $2 million, before deducting fees and expenses.
• The company intends to use the net proceeds for working capital and general corporate purposes.
• Certain members of the board and management participated in the offering, agreeing to a 180-day lock-up period.
• Alere Financial Partners, LLC acted as the placement agent and will receive a cash fee and warrants to purchase up to 58,182 shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the company is securing necessary funding for growth, but there is some dilution risk for existing shareholders. The management's comments are optimistic, and the offering is structured in a standard way.

Positives

• The offering is expected to provide NexGel with $2 million in gross proceeds to strengthen its balance sheet.
• The funds will be used to increase inventory levels, marketing spend for Silly George, and support growth in receivables.
• The capital raise will also allow the company to pursue potential acquisition opportunities.
• The participation of insiders in the offering demonstrates confidence in the company's prospects.

Negatives

• The offering will dilute existing shareholders by issuing 727,272 new shares of common stock.
• The company will incur placement agent fees and other offering expenses, reducing the net proceeds.
• The warrants issued in the offering could further dilute shareholders if exercised.

Risks

• The closing of the offering is subject to customary closing conditions, which may not be met.
• The company's ability to effectively use the proceeds for working capital and acquisitions is not guaranteed.
• The exercise of warrants could lead to further dilution of existing shareholders.
• The company's future performance is subject to various risks and uncertainties as detailed in their annual report.

Future Outlook

The company intends to use the net proceeds from the offering for working capital, general corporate purposes, increasing inventory levels, marketing spend, and pursuing acquisition opportunities.

Management Comments

• Adam Levy, CEO of NEXGEL, stated that the financing will strengthen the balance sheet, increase inventory levels and marketing spend for Silly George, support growth in receivables, and provide capital for acquisitions.

Industry Context

This capital raise is a common strategy for companies in the medical and OTC product space to fund growth initiatives, particularly for companies like NexGel that are expanding their product lines and customer base. The use of a registered direct offering is a standard method for raising capital from institutional investors.

Comparison to Industry Standards

• The offering structure, including units with common stock and warrants, is a typical approach for small-cap companies seeking capital.
• The placement agent fees of 8% for non-affiliates and 4% for affiliates are within the typical range for such transactions.
• The warrant exercise price of $4.25 is a common discount to the current market price to incentivize investors.
• The lock-up period of 180 days for insiders is a standard practice to prevent immediate selling pressure on the stock.

Related Party Transactions

• Certain members of the board of directors and management have agreed to purchase an aggregate of 19,659 units in the Offering.

Stakeholder Impact

• Shareholders will experience dilution due to the issuance of new shares.
• The company's financial position will be strengthened, potentially benefiting long-term investors.
• Employees may benefit from increased investment in the company's growth.
• Customers may benefit from increased product availability and marketing efforts.
• Creditors may view the company more favorably due to the improved financial position.

Next Steps

• The company will close the offering on or about November 13, 2024.
• The company will issue the shares and warrants to the investors.
• The company will use the net proceeds for working capital, general corporate purposes, and potential acquisitions.
• The company will file a prospectus supplement with the SEC.

Key Dates

Keywords

registered direct offering, common stock, warrants, capital raise, placement agent, working capital, acquisition, dilution, lock-up period, NexGel